Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem Cells

Cancer stem cells (CSCs), or tumor-initiating cells, are a small subset of cancer cells with the capacity for self-renewal and differentiation, which have been shown to drive tumor initiation, progression, and metastasis in many types of cancer. Moreover, therapeutic regimens, such as cisplatin and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Peng-Chan, Hsieh, Hao-Yu, Chu, Po-Chen, Chen, Ching S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073995/
https://www.ncbi.nlm.nih.gov/pubmed/30004423
http://dx.doi.org/10.3390/ijms19071939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073995/
https://www.ncbi.nlm.nih.gov/pubmed/30004423
http://dx.doi.org/10.3390/ijms19071939

Ejemplares similares